Cargando…

Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens

Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification o...

Descripción completa

Detalles Bibliográficos
Autores principales: Harb, Jean, Mennesson, Nicolas, Lepetit, Cassandra, Fourny, Maeva, Louvois, Margaux, Bosseboeuf, Adrien, Allain-Maillet, Sophie, Decaux, Olivier, Moreau, Caroline, Tallet, Anne, Piver, Eric, Moreau, Philippe, Salle, Valéry, Bigot-Corbel, Edith, Hermouet, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922508/
https://www.ncbi.nlm.nih.gov/pubmed/33669483
http://dx.doi.org/10.3390/cells10020438
_version_ 1783658706275139584
author Harb, Jean
Mennesson, Nicolas
Lepetit, Cassandra
Fourny, Maeva
Louvois, Margaux
Bosseboeuf, Adrien
Allain-Maillet, Sophie
Decaux, Olivier
Moreau, Caroline
Tallet, Anne
Piver, Eric
Moreau, Philippe
Salle, Valéry
Bigot-Corbel, Edith
Hermouet, Sylvie
author_facet Harb, Jean
Mennesson, Nicolas
Lepetit, Cassandra
Fourny, Maeva
Louvois, Margaux
Bosseboeuf, Adrien
Allain-Maillet, Sophie
Decaux, Olivier
Moreau, Caroline
Tallet, Anne
Piver, Eric
Moreau, Philippe
Salle, Valéry
Bigot-Corbel, Edith
Hermouet, Sylvie
author_sort Harb, Jean
collection PubMed
description Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification of targets for >60% purified monoclonal immunoglobulins (Igs). Searching for additional targets, we selected 28 purified monoclonal Igs whose antigen was not represented on the MIAA and GlcSph assays; their specificity of recognition was then analyzed using microarrays consisting of 3760 B-cell epitopes from 196 pathogens. The peptide sequences PALTAVETG and PALTAAETG of the VP1 coat proteins of human poliovirus 1/3 and coxsackievirus B1/B3, respectively, were specifically recognized by 6/28 monoclonal Igs. Re-analysis of patient cohorts showed that purified monoclonal Igs from 10/155 MGUS/SM (6.5%) and 3/147 MM (2.0%) bound to the PALTAVETG or PALTAAETG epitopes. Altogether, PALTAV/AETG-initiated MGUS are not rare and few seem to evolve toward myeloma.
format Online
Article
Text
id pubmed-7922508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79225082021-03-03 Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens Harb, Jean Mennesson, Nicolas Lepetit, Cassandra Fourny, Maeva Louvois, Margaux Bosseboeuf, Adrien Allain-Maillet, Sophie Decaux, Olivier Moreau, Caroline Tallet, Anne Piver, Eric Moreau, Philippe Salle, Valéry Bigot-Corbel, Edith Hermouet, Sylvie Cells Article Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification of targets for >60% purified monoclonal immunoglobulins (Igs). Searching for additional targets, we selected 28 purified monoclonal Igs whose antigen was not represented on the MIAA and GlcSph assays; their specificity of recognition was then analyzed using microarrays consisting of 3760 B-cell epitopes from 196 pathogens. The peptide sequences PALTAVETG and PALTAAETG of the VP1 coat proteins of human poliovirus 1/3 and coxsackievirus B1/B3, respectively, were specifically recognized by 6/28 monoclonal Igs. Re-analysis of patient cohorts showed that purified monoclonal Igs from 10/155 MGUS/SM (6.5%) and 3/147 MM (2.0%) bound to the PALTAVETG or PALTAAETG epitopes. Altogether, PALTAV/AETG-initiated MGUS are not rare and few seem to evolve toward myeloma. MDPI 2021-02-19 /pmc/articles/PMC7922508/ /pubmed/33669483 http://dx.doi.org/10.3390/cells10020438 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Harb, Jean
Mennesson, Nicolas
Lepetit, Cassandra
Fourny, Maeva
Louvois, Margaux
Bosseboeuf, Adrien
Allain-Maillet, Sophie
Decaux, Olivier
Moreau, Caroline
Tallet, Anne
Piver, Eric
Moreau, Philippe
Salle, Valéry
Bigot-Corbel, Edith
Hermouet, Sylvie
Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
title Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
title_full Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
title_fullStr Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
title_full_unstemmed Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
title_short Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
title_sort comparison of monoclonal gammopathies linked to poliovirus or coxsackievirus vs. other infectious pathogens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922508/
https://www.ncbi.nlm.nih.gov/pubmed/33669483
http://dx.doi.org/10.3390/cells10020438
work_keys_str_mv AT harbjean comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT mennessonnicolas comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT lepetitcassandra comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT fournymaeva comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT louvoismargaux comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT bosseboeufadrien comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT allainmailletsophie comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT decauxolivier comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT moreaucaroline comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT talletanne comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT pivereric comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT moreauphilippe comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT sallevalery comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT bigotcorbeledith comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens
AT hermouetsylvie comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens